Schedule 13G ownership disclosure

DA32 Life Science Tech Acquisition Corp.

Security class unavailable · CUSIP: 23312M106

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,865,991
Percent of class
11.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001678858-22-000132
Form type
SC 13G/A
Filer
DA32 Life Science Tech Acquisition Corp.
CIK
CIK 1863294
Filed
Feb 04, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub